A Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients With Advanced Cancer

NCT05659732 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia
Lymphoma, Mantle-Cell

Interventions

DRUG: PEP07

Sponsor

PharmaEngine